
|Articles|August 7, 2015
FDA Warning on MS Drug Highlights Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
A look back at the top stories of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/fda-warning-on" target="_blank">View the story "FDA Warning on MS Drug Highlights Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Should Know About Long COVID and Brain Health
2
Expert: Why Cutting Alcohol May Enhance GLP-1 Outcomes in Patients With Obesity and Diabetes Risk
3
Radio Frequency Identification is Revolutionizing Medication Management
4
Early-Line Immunotherapy Challenges the Role of Transplant in Multiple Myeloma
5
















